Cytomos is a series a startup based in United Kingdom. 1 investor tracked.
Cytomos is a company founded in 2018 headquartered in the United Kingdom. Its most recent tracked round is Series A. Brouky records 1 investor associated with the company.
Cytomos develops novel cell analysis and sorting tools for bioprocessing and cell therapy applications. Their technology enables rapid, label-free, single-cell analysis, providing detailed insights into cell health and behavior.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.